Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
10/2000
10/26/2000WO2000037646A3 Group b streptococcus proteins, and their use
10/26/2000WO2000034294A3 Tumor necrosis factor receptor homologue-1 ('trh1')
10/26/2000WO2000018230A9 Combination of bisphosphonate and tetracycline
10/26/2000WO2000017191A3 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
10/26/2000WO2000017190A3 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
10/26/2000DE19918211A1 New 2-carbocyclyl-benzimidazole-carboxamide derivatives, are PARP inhibitors useful e.g. for treating neurodegenerative disease, epilepsy, ischemia, tumors, inflammation or diabetes
10/26/2000CA2371972A1 Ent-steroids as selectively active estrogens
10/26/2000CA2370570A1 Dna encoding the human vanilloid receptor vr1
10/26/2000CA2370417A1 Substituted azoles
10/26/2000CA2370301A1 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
10/26/2000CA2370272A1 Protease activated receptor 2 variants
10/26/2000CA2370268A1 Treatment of adult rheumatoid arthritis by oral administration of pooled human immunoglobulin and an antacid
10/26/2000CA2370130A1 Chewing gum with dental benefits including calcium in a food grade acid
10/26/2000CA2370129A1 Methods and compositions for modulating an immune response
10/26/2000CA2370127A1 Novel method of treatment
10/26/2000CA2370126A1 Estrogen receptor-.beta. ligands
10/26/2000CA2368839A1 D-form polypeptide which induces immune tolerance and methods of use
10/26/2000CA2367395A1 Cyclic amine derivatives and use thereof
10/26/2000CA2367359A1 Dibenzoazulene derivatives for the treatment of thrombosis, osteoporosis, arteriosclerosis
10/26/2000CA2367356A1 New compounds, their preparation and use
10/26/2000CA2363689A1 Compounds useful as phosphotyrosine mimics
10/26/2000CA2330231A1 Composition and method for modulating dendritic cell-t cell interaction
10/25/2000EP1046651A1 Composition and method for modulating dendritic cell-T interaction
10/25/2000EP1046410A2 Calcium and magnesium containing phosphate binding agent for the treatment of hyperphosphatemia
10/25/2000EP1045845A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity
10/25/2000EP1045836A1 Pyridones as src family sh2 domain inhibitors
10/25/2000EP1045833A1 2,3-substituted indole compounds as cox-2 inhibitors
10/25/2000EP1045822A1 Certain diterpenes and extracts or concentrates of curcuma amada containing them for use as medicaments
10/25/2000EP1045694A1 Method of increasing bone volume using non-naturally-occurring fp selective agonists
10/25/2000EP1045690A1 Benzenesulfonamide inhibitors of pde-iv and their therapeutic use
10/25/2000CN1271289A Osteoblast-specific mitogens and drugs containing such compounds
10/25/2000CN1271284A Vitronectin receptor antagonist
10/25/2000CN1271279A Amide derivatives for the treatment of diseases mediated by cytokines
10/25/2000CN1270960A Process for preparing growth hormone cinogenic agent
10/25/2000CN1270836A Pain stopping ointment and its preparation
10/25/2000CN1270833A Bone fracture setting medicine powder
10/25/2000CN1270821A Bone fracture setting ointment
10/25/2000CN1270819A Bone and muscle bolus
10/25/2000CN1270811A Chinese medicine for treating arthralgia and its preparation
10/25/2000CN1057700C Chinese medicine for treating gout
10/25/2000CN1057698C Medicine for curing bone fracture
10/25/2000CN1057694C Plaster for treating hyperosteogeny and its prepn. method
10/25/2000CN1057692C Chinese patent drug 'Tongluoxiaocisan' for curing hyperosteogeny
10/24/2000US6136974 Pyrrolo[3,4-D]Pyrimidinone derivatives and their use as medicaments
10/24/2000US6136859 Mixture of selenmethionine, carotene, ascorbic acid, tocopherol, methionine and coenzyme q10 in a carrier
10/24/2000US6136787 Interleukin 1β protease and interleukin 1β protease inhibitors
10/24/2000US6136596 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
10/24/2000CA2072283C Process for the preparation of diacetylrhein
10/19/2000WO2000061774A2 Bone morphogenic proteins
10/19/2000WO2000061757A1 Tumor necrosis factor homologs and nucleic acids encoding the same
10/19/2000WO2000061755A2 Secreted human proteins
10/19/2000WO2000061754A2 Human proteins and polynucleotides encoding them
10/19/2000WO2000061750A2 TYROSINE KINASE SUBSTRATE (Tks) PROTEINS
10/19/2000WO2000061748A1 48 human secreted proteins
10/19/2000WO2000061627A1 49 human secreted proteins
10/19/2000WO2000061620A1 49 human secreted proteins
10/19/2000WO2000061608A2 Low-molecular inhibitors of complement proteases
10/19/2000WO2000061604A2 Pharmaceutical compounds
10/19/2000WO2000061596A1 50 human secreted proteins
10/19/2000WO2000061587A1 Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines
10/19/2000WO2000061583A1 Xanthine derivatives and analogs as cell signaling inhibitors
10/19/2000WO2000061581A1 Amine derivatives
10/19/2000WO2000061576A1 Triarylimidazoles
10/19/2000WO2000061569A1 Adamantane derivatives
10/19/2000WO2000061551A2 Pyrimidine-2-one derivatives as integrin receptor ligands
10/19/2000WO2000061545A1 Methods for solid phase combinatorial synthesis of integrin inhibitors
10/19/2000WO2000061541A2 Pharmaceutical compounds
10/19/2000WO2000061230A2 Estrogen receptors-beta antagonism and bone diseases
10/19/2000WO2000061171A2 Uses of mammalian ox2 protein and related reagents
10/19/2000WO2000061167A2 TREATMENT OF MYELOMA BONE DISEASE WITH PROTEASOMAL AND NF-λB ACTIVITY INHIBITORS
10/19/2000WO2000061152A1 Management of pain after joint surgery
10/19/2000WO2000061123A2 Compound preparation made of vitamin d metabolites or vitamin d analogues and an oestrogenic component for treating osteoporosis
10/19/2000WO2000061112A2 Solubilized pharmaceutical composition for parenteral administration
10/19/2000WO2000061111A1 A pharmaceutical formulation comprising an bisphosphonate and an additive agent providing an enhanced absorption of the bisphosphonate
10/19/2000WO2000060950A1 Dietary supplement derived from fermented milks for the prevention of osteoporosis
10/19/2000WO2000041505A3 Anthranilic acid derivatives
10/19/2000WO2000029551A3 Cells, culture methods, and their use in autologous transplantation therapy
10/19/2000WO2000012720A8 Elongase genes and uses thereof
10/19/2000WO2000007996A8 Pyrazoles as estrogen receptor modulators
10/19/2000DE19917930A1 Treating estrogen deficiency associated disorders, e.g. menopausal problems, osteoporosis, neoplasia or neurodegenerative disease, using new or known ent-steroids having bone-selective estrogenic activity
10/19/2000DE19916837A1 New di- or tetrahydro-benzoazulene derivatives, are integrin inhibitors useful e.g. for treating thrombosis, coronary heart disease, arteriosclerosis, tumors, osteoporosis or rheumatoid arthritis
10/19/2000DE19916419A1 Kombinationspräparat aus Vitamin-D-Metaboliten oder Vitamin-D-Analoga und einer östrogenen Komponente zur Behandlung von Osteoporose A combination preparation of vitamin D metabolites or vitamin D analogues and of an estrogenic component in the treatment of osteoporosis
10/19/2000DE19915465A1 Verwendung eines Caspase-Inhibitors zur Proliferationshemmung von Zellen und Verwendung eines oder mehrerer Caspase-Inhibitors/en zur Behandlung von Erkrankungen beruhend auf Lymphozyten-Hyperproliferation oder zur Suppression einer Immunantwort durch Lymphozyten Using a Caspase inhibitor for the inhibition of proliferation of cells and using one or more caspase inhibitor / s for the treatment of diseases based on lymphocyte hyperproliferation or for suppression of an immune response by lymphocytes
10/19/2000CA2371223A1 49 human secreted proteins
10/19/2000CA2371172A1 50 human secreted proteins
10/19/2000CA2370767A1 49 human secreted proteins
10/19/2000CA2370425A1 Pharmaceutical compounds
10/19/2000CA2369981A1 Therapeutic compounds for inhibiting interleukin-12 signaling and methods for using same
10/19/2000CA2369971A1 Aryl or heteroaryl fused imidazole derivatives, their pharmaceutical compositions and agents, and uses thereof
10/19/2000CA2369454A1 Uses of mammalian ox2 protein and related reagents
10/19/2000CA2369420A1 Treatment of myeloma bone disease with proteasomal and nf-kb activity inhibitors
10/19/2000CA2369378A1 Low-molecular inhibitors of complement proteases
10/19/2000CA2369301A1 Management of pain after joint surgery
10/19/2000CA2368829A1 Adamantane derivatives
10/19/2000CA2368648A1 Estrogen receptors and bone
10/19/2000CA2368049A1 Integrin receptor ligands
10/19/2000CA2365917A1 Bone morphogenic proteins
10/19/2000CA2365913A1 Tumor necrosis factor receptor homologs and nucleic acids encoding the same
10/19/2000CA2365910A1 Human proteins and polynucleotides encoding them
10/19/2000CA2365905A1 48 human secreted proteins
1 ... 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 ... 820